What patient factors prompt you to consider starting dupilumab in patients with COPD?
2 Answers
Mednet Member
Pulmonology · Columbia Doctors Pulmonology
The factors I consider are recurrent exacerbations, symptoms despite triple therapy, and an eosinophil count that is greater than 300.
What is unclear is the decision regarding chronic azithromycin and/or roflumilast versus dupilumab. It looks like roflumilast was not allowed in the study, and appar...